Company Number: 15127691

Analysis Date: 2025-07-20 11:25 UTC

1. Risk Rating: HIGH
   The company shows a negative net asset position (£-5,442) with current liabilities significantly exceeding current assets, indicating potential solvency and liquidity issues despite being newly incorporated.

2. Key Concerns:

• Negative Net Assets and Working Capital Deficit: Current liabilities (£26,173) far exceed current assets (£4,713), resulting in net current liabilities of £21,460 and overall net liabilities of £5,442, raising solvency concerns.
• Early Stage with Minimal Operational History: Incorporated in September 2023 with only one employee and micro-entity accounts, limiting historical financial performance data to assess operational sustainability.
• Single Director and Shareholder Control: Full ownership and control by one individual (Safinatu Sarki) may increase governance risks and limit independent oversight.

3. Positive Indicators:

• Compliance with Filing Requirements: Both accounts and confirmation statement are filed on time, indicating good regulatory compliance so far.
• Clear Business Focus: Operating in "Other human health activities" with an active website and customer contact details, suggesting some commercial activity is underway.
• Micro-entity Status: Minimal statutory audit requirements reduce immediate compliance costs.

4. Due Diligence Notes:

• Verify the nature and timing of the liabilities causing the working capital shortfall; assess if these are trade creditors, loans, or accrued expenses.
• Review cash flow forecasts and bank statements to determine liquidity sufficiency to meet short-term obligations.
• Understand the business model, revenue generation timeline, and capital injection plans to support ongoing operations.
• Consider director’s background and capacity to manage financial pressures given sole control.